- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04918303
Skin Sympathetic Nerve Activity and Cardiac Arrhythmia (SKNA)
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Mélèze Hocini, MD
- Phone Number: +33 (0)5 57 63 34 06
- Email: meleze.hocini@chu-bordeaux.fr
Study Contact Backup
- Name: Maëlle Vallade
- Phone Number: +33 (0)5 24 54 92 58
- Email: maelle.vallade@chu-bordeaux.fr
Study Locations
-
-
-
Pessac, France, 33600
- Recruiting
- Bordeaux University Hospital
-
Contact:
- Mélèze Hocini, MD
- Phone Number: +33 (0)5 57 63 34 06
- Email: meleze.hocini@chu-bordeaux.fr
-
Contact:
- Maëlle Vallade
- Phone Number: +33 (0)5 24 54 92 58
- Email: maelle.vallade@chu-bordeaux.fr
-
Principal Investigator:
- Mélèze Hocini, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patient hospitalized at Bordeaux University Hospital for sudden death, ventricular tachycardia, persistent or paroxysmal atrial fibrillation treated by ablation and/or vein of Marshall ethanol infusion
Exclusion Criteria:
- pregnancy,
- patient under 18 year old,
- patient with a cardiac stimulation device
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: SKNA group
|
The coupled recording of the sympathetic nervous activity of the skin and of an ECG will be carried out using the ME6000 device, CE marked, from the Bittium company. It will be performed for a maximum period of one hour at Day 1, Post-procedure between Day 1 and discharge from hospital, and month 6 |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Delay between the discharge of the sympathetic system and the rhythmic event.
Time Frame: Day 1
|
Temporal correlation of occurrence of sympathetic electrical event and cardiac arrhythmia by the MacNemar test will be performed.
|
Day 1
|
Delay between the discharge of the sympathetic system and the rhythmic event.
Time Frame: Day 2
|
Temporal correlation of occurrence of sympathetic electrical event and cardiac arrhythmia by the MacNemar test will be performed.
|
Day 2
|
Delay between the discharge of the sympathetic system and the rhythmic event.
Time Frame: Month 6
|
Temporal correlation of occurrence of sympathetic electrical event and cardiac arrhythmia by the MacNemar test will be performed.
|
Month 6
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mélèze Hocini, MD, University Hospital, Bordeaux
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHUBX 2020/55
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventricular Tachycardia
-
University of PretoriaCompletedSupra-ventricular TachycardiaSouth Africa
-
Ottawa Heart Institute Research CorporationNot yet recruitingVentricular Fibrillation | Ventricular Tachycardia | Ventricular Arrhythmias | Recurrent Ventricular Tachycardia
-
Armgo Pharma, Inc.Food and Drug Administration (FDA)RecruitingCatecholaminergic Polymorphic Ventricular Tachycardia Type 1United States, Netherlands
-
University of Turin, ItalyAzienda Unità Sanitaria Locale Reggio Emilia; IRCCS Sacro Cuore Don Calabria... and other collaboratorsRecruitingRefractory Ventricular TachycardiaItaly
-
Thermedical, Inc.Not yet recruitingRefractory Ventricular TachycardiaUnited States, Canada
-
John SappCompleted
-
University of California, Los AngelesCompletedRefractory Ventricular TachycardiaUnited States
-
Hospital General Universitario Gregorio MarañonCompletedMonomorphic Ventricular TachycardiaSpain
-
Abbott Medical DevicesTerminatedMonomorphic Ventricular TachycardiaUnited States, United Kingdom, France, Australia, Italy
-
Abbott Medical DevicesWithdrawn
Clinical Trials on SKNA recording
-
University of California, San FranciscoConquer Cancer FoundationActive, not recruitingProstate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
University of UtahHuntsman Cancer InstituteTerminated
-
Centre d'Investigation Clinique et Technologique...National Research Agency, FranceCompletedAttitude to ComputersFrance
-
NewPace LtdCompletedArrhythmias, Cardiac | TachyarrhythmiaUnited States
-
Rambam Health Care CampusUnknown
-
Guy's and St Thomas' NHS Foundation TrustUniversity of Oxford; Engineering and Physical Sciences Research Council, UKCompleted
-
Prof. Dr. Volker Arnd CoenenUniversity of FreiburgRecruiting
-
G-Tech CorporationEminence Clinical Research, Inc.RecruitingPost-operative IleusUnited States
-
Stanford UniversityG-Tech Corporation; The Leona M. and Harry B. Helmsley Charitable TrustCompleted